Journal of Schizophrenia Disorders And Therapy

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Schizophrenia Disorders And Therapy-Psychopharmacology-Stephan Heres


Technische Universitaet Muenchen,

Send an Email

Stephan Heres


Ismaningerstrasse 26,
81675 Muenchen,​

Research Interests:

  • Psychopharmacology
  • Long-acting injections
  • Antipsychotics
  • Clinical trial methodology
  • BIAS in clinical trials
  • Shared decision making



  1. The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
  2. Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
  3. Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method.
  4. Treatment of early episode in patients with schizophrenia: The role of long acting antipsychotics.
  5. Pharmacokinetics of olanzapine long-acting injection: The clinical perspective.
  6. Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method.
  7. Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany.
  8. Clinicians' Attitudes Toward the Use of Long-Acting Injectable Antipsychotics.
  9. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis.
  10. Oral versus Depot Antipsychotic Drugs for Schizophrenia—a Critical Systematic Review and Meta-Analysis of Randomised Long-Term Trials.